EMICIZUMAB
-
Novel treatments in bleeding disorders: The EHC November Review
CLICK HERE to access the November 2021 review of novel treatments in haemophilia and other bleeding disorders by the European Haemophilia Consortium.
-
Hemlibra rollout continues via CBS, more uncertainty in Quebec
November 10, 2021 (Montreal) – The Hemlibra rollout continues in provinces served by Canadian Blood Services (CBS). Since access requests from physicians began to be...
-
CBS announces FVIII and FIX products for 2022-2025
November 3, 2021, Ottawa – Canadian Blood Services (CBS) has announced the results of its Request for Proposals (RFP) to supply recombinant factor VIII and...
-
Hemlibra request form available as of today in areas served by Canadian Blood Services
October 18, 2021, Ottawa – Canadian Blood Services (CBS) announced in its October 18 Customer Letter that the request form for emicizumab (Hemlibra) is now...
-
FVIII/IX tenders: how are they done?
Every two or three years, Canadian Blood Services (CBS) and Héma-Québec put out “Requests for Proposals” (RFP) to companies with recombinant factor VIII and IX...